Generation of an Induced Pluripotent Stem Cell Line with the Constitutive EGFP Reporter
Authors:
- 1 January 2020
- book chapter
- Published by Springer Nature
- Vol. 2155, 11-21
Abstract
The discovery of induced pluripotent stem cell (iPSC) technology has provided a versatile platform for basic science research and regenerative medicine. With the rise of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) systems and the ease at which they can be utilized for gene editing, creating genetically modified iPSCs has never been more advantageous for studying both organism development and potential clinical applications. However, to better understand the behavior and true therapeutic potential of iPSCs and iPSC-derived cells, a tool for labeling and monitoring these cells in vitro and in vivo is needed. Here, we describe a protocol that provides a straightforward method for introducing a stable, highly expressed fluorescent protein into iPSCs using the CRISPR/Cas9 system and a standardized donor vector. The approach involves the integration of the EGFP transgene into the transcriptionally active adeno-associated virus integration site 1 (AAVS1) locus through homology directed repair. The knockin of this transgene results in the generation of iPSC lines with constitutive expression of the EGFP protein that also persists in differentiated iPSCs. These EGFP-labeled iPSC lines are ideal for assessing iPSC differentiation in vitro and evaluating the distribution of iPSC-derived cells in vivo after transplantation into model animals. Key words Induced pluripotent stem cells iPSCs Nucleofection CRISPR/Cas9 Fluorescent proteinKeywords
This publication has 12 references indexed in Scilit:
- Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC PurificationMolecular Therapy Nucleic Acids, 2018
- Delivering CRISPR: a review of the challenges and approachesDrug Delivery, 2018
- Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organizationMolecular Biology of the Cell, 2017
- CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor VectorsCell Reports, 2017
- RNA‐Generated and Gene‐Edited Induced Pluripotent Stem Cells for Disease Modeling and TherapyJournal of Cellular Physiology, 2016
- Overview of CRISPR–Cas9 BiologyCold Spring Harbor Protocols, 2016
- Modified mRNA as an alternative to plasmid DNA (pDNA) for transcript replacement and vaccination therapyExpert Opinion on Biological Therapy, 2015
- Disease modeling and cell based therapy with iPSC: future therapeutic option with fast and safe applicationBlood Research, 2014
- Safe harbours for the integration of new DNA in the human genomeNature Reviews Cancer, 2011
- Cell-free synthesis of recombinant proteins from PCR-amplified genes at a comparable productivity to that of plasmid-based reactionsBiochemical and Biophysical Research Communications, 2005